Ezetimibe and Lunesta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Lunesta (eszopiclone). Common drug interactions include anxiety among females and nephrotic syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Lunesta. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Lunesta?

Lunesta has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 26,936 Lunesta users. Check the latest studies of Lunesta.

On Jul, 17, 2026

28 people who take Ezetimibe and Lunesta together, and have interactions are studied.

Ezetimibe and Lunesta drug interactions.

What are the common drug interactions of Ezetimibe and Lunesta, by gender? *:

female:

Anxiety
Fall
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood creatine phosphokinase increased
Myalgia (muscle pain)
Pyrexia (fever)
Urinary tract infection
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

male:

Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Abdominal pain upper
Oxygen saturation decreased
Blood magnesium decreased
Chronic kidney disease
Diarrhoea
Dry mouth
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Metastasis (spreadable cancer to other organ from origin)

What are the common drug interactions of Ezetimibe and Lunesta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Blood pressure increased
Bone density decreased
Chronic kidney disease
Emotional distress
Exercise tolerance decreased
Gait disturbance
Headache (pain in head)

60+:

Fall
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Abdominal distension
Constipation
Decreased appetite
Diastolic dysfunction
Dilatation ventricular
Ejection fraction decreased (systolic heart failure)
Eye swelling
Heart rate increased

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 21.43%
Pain: 5 people, 17.86%
Constipation: 4 people, 14.29%
Diabetes: 4 people, 14.29%
Dry Eyes (lack of adequate tears): 4 people, 14.29%
Type 2 Diabetes: 4 people, 14.29%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 10.71%
Sleep Disorder: 3 people, 10.71%
Anaemia (lack of blood): 3 people, 10.71%
Stress And Anxiety: 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Lunesta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously